WITHDRAWN: JUN and ATF3 are deficient in prostate cancer patients and their delivery in vivo via lipid nanoparticles has therapeutic efficacy by enhancing immune surveillance

Liang Kan; Yongye Huang; Zhongyuan Liu

Pharmacological Research (Aug 2023)

WITHDRAWN: JUN and ATF3 are deficient in prostate cancer patients and their delivery in vivo via lipid nanoparticles has therapeutic efficacy by enhancing immune surveillance

Liang Kan,
Yongye Huang,
Zhongyuan Liu

Affiliations

Liang Kan: Department of Geriatrics, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, PR China
Yongye Huang: College of Life and Health Sciences, Northeastern University, Shenyang, 110169, Liaoning, PR China
Zhongyuan Liu: Department of Urology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, PR China; Corresponding author. Department of Urology, Shengjing Hospital of China Medical University, No. 36, Sanhao Street, Heping District, Shenyang, 110004, Liaoning, PR China.

Journal volume & issue: Vol. 194
p. 106753

Abstract

Read online

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause.The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/policies/article-withdrawal

Published in Pharmacological Research

ISSN: 1096-1186 (Online)
Publisher: Elsevier
Country of publisher: United Kingdom
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: https://www.sciencedirect.com/journal/pharmacological-research

About the journal